Cargando...
Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers
Trastuzumab, an epidermal growth factor receptor 2 (HER2) targeting humanized monoclonal antibody, has been approved for the treatment HER2-positive breast cancer and HER2-positve metastatic gastric cancer. However, cardiotoxicity associated with its clinical application poses challenges for clinici...
Guardado en:
| Publicado en: | Antib Ther |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6131716/ https://ncbi.nlm.nih.gov/pubmed/30215054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tby003 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|